Poseida and Roche to develop cell therapies for hematologic cancers
Poseida could get research, development, launch and net sales milestones and other payments totalling up to $6bn.
Cytiva-Cell & Gene Therapy
Latest in
Cytiva-Cell & Gene Therapy
Samsung Biologics and GreenLight conclude Covid-19 vaccine engineering run
The clinical trial of GreenLight’s Covid-19 booster vaccine is anticipated to commence this year.
GreenLight and US NIH partner to develop Covid-19 vaccine for variants
The parties aim to manufacture vaccines with lasting immune responses compared to existing ones.
Moderna signs contract to supply Covid-19 booster vaccines to the US
The initial 66 million vaccine doses are anticipated to be supplied this year.
Moderna’s Covid-19 shot gets Australian TGA provisional approval for kids
In Phase II/III KidCOVE trial, the vaccine offered a strong neutralising antibody response in children.
Health Canada grants approval for Moderna’s Covid-19 vaccine in children
In Phase II/III KidCOVE trial, two doses of the vaccine offered strong neutralising antibody response in the young children.
Avrobio receives orphan drug designation for Hunter syndrome gene therapy
Avrobio is expected to initiate a Phase I/II clinical trial for Hunter syndrome in partnership with the University of Manchester.
GenScript and ACT partner to develop new CAR-T cell therapies
The ACT platform will be commissioned to manufacture raw materials for the subsequent pipeline of ACT.